Platform
Traditional brain medications often caused side effects due to a lack of understanding about disease pathways. Our development platform draws upon our unique competency in understanding the circuitry of the brain and novel business approaches.
.jpg)
Unprecedented visibility into neuroscience
Our research team has been a leader in the field of neuroscience, publishing groundbreaking discoveries in prestigious journals. This deep understanding of the brain allowed us to pinpoint the exact protein responsible for chronic cough, paving the way for targeted therapies.
Maximizing value through intellectual property
To ensure our efficient drug development benefits patients, we employ robust intellectual property strategies to protect our discoveries. This expert-driven approach ensures that the solutions we develop continue to deliver value and fuel solutions for patients who need them most over the long-term.
Target-driven therapeutic molecule identification
Our drug discovery method prioritizes finding existing compounds with the right fit ("selectivity") to target the cough reflex pathway. This worldwide search leverages various data sources to find a suitable pre-existing molecule, significantly speeding up initial development stages.
Acceleration through clinical data
By utilizing pre-existing safety data from past trials or even market use of similar molecules, our drug development approach reduces risks and increases success rates. This "platform approach" allows for faster, cheaper development and more confident drug creation.